Clinical & Diagnostic

Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

Olympus Strengthens its Medical Portfolio with Successful Acquisition of Taewoong Medical Co., Ltd, a Leading Korean Gastrointestinal Stent Company...

Veeva Pulse Shows Doctors Opening Up Two-Way Communications Doubles Digital Engagement

Digital channels are emerging as the preferred method for engagement with field teams in Asia...

Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac

Brain Navi Celebrates Milestone Achievement: Successfully Completes 100 Surgical Procedures with NaoTrac Navigation System...

UNFO Introduces Innovative Corrective Foot Brace For Newborns, Elevating Pediatric Orthopedic Care In The U.S.

Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing The Need For Casting And Surgical Intervention...

“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company...

Targeted Battle Against HPV

Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets ...

Varian & Nova Scotia Health Forge Groundbreaking Oncology Partnership for Cancer Care Advancements

Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship....

Lucem Health Launches Reveal for Faster AFib-Related Stroke Treatment

Groundbreaking Solution Identifies Undiagnosed AFib and Speeds Treatments Proven to Prevent Strokes ...

TMRW Life Sciences Expands Globally Entering UK Fertility Market

The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW's State-of-the-Art Technology for the Safe Management of Frozen Eggs and Embryos Providing a New Standard of Care for Fertility Patients...

Nestlé Study: Optifast® Meal Replacement Reduces Weight and Cardiovascular Risks

For the 4 in 10 U.S. adults living with obesity, and therefore at increased risk of heart disease,1 Optifast is a non-invasive option to potentially lose weight and preserve heart health ...